Lv6
1620 积分 2023-06-16 加入
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma
2天前
已完结
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
2天前
已完结
Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and network meta-analysis
2天前
已完结
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open- label, randomised phase III AIO/EORTC trial (POWER)
18天前
已完结
The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma
1个月前
已完结
A retrospective real-world study of nimotuzumab combined with chemotherapy for advanced pancreatic cancer
1个月前
已关闭
Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer
1个月前
已完结
老年局部晚期食管癌同步放化疗序贯信迪利单抗免疫治疗的疗效
2个月前
已完结
皖公网安备34019202002308
